Statistics
Total Visits
| Views | |
|---|---|
| Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer | 1208 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer | 8 | 8 | 12 | 24 | 54 | 28 | 16 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 1056 |
| United States | 112 |
| China | 4 |
| Ireland | 4 |
| Ukraine | 4 |
| France | 2 |
| Iran | 2 |
| Sweden | 2 |
| Singapore | 2 |
Top City Views
| Views | |
|---|---|
| Armidale | 798 |
| Yeronga | 180 |
| Ashburn | 54 |
| Melbourne | 34 |
| Louisville | 20 |
| San Mateo | 12 |
| Sydney | 8 |
| Alameda | 6 |
| Dublin | 4 |
| Changi | 2 |